View in EDS

Design of a Tumor Binding GMCSF as Intratumoral Immunotherapy of Solid Tumors.

Saved in:

Bibliographic Details
Title:	Design of a Tumor Binding GMCSF as Intratumoral Immunotherapy of Solid Tumors.
Authors:	Chakravarti AR; Bioengineering Program, The University of Kansas, Lawrence, Kansas 66045, United States., Groer CE; HylaPharm, LLC, Lawrence, Kansas 66047, United States.; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States., Gong H; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States., Yudistyra V; Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66045, United States., Forrest ML; HylaPharm, LLC, Lawrence, Kansas 66047, United States.; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States., Berkland CJ; Bioengineering Program, The University of Kansas, Lawrence, Kansas 66045, United States.; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States.; Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66045, United States.
Source:	Molecular pharmaceutics [Mol Pharm] 2023 Apr 03; Vol. 20 (4), pp. 1975-1989. Date of Electronic Publication: 2023 Feb 24.
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-8392 (Electronic) Linking ISSN: 15438384 NLM ISO Abbreviation: Mol Pharm Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1543-8392
DOI:	10.1021/acs.molpharmaceut.2c00897